The US Food and Drug Administration on January 7 approved Plainsboro, NJ-based Integra’s Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers (DFUs) that haven’t healed after six weeks and don’t involve exposure of the joint capsule, tendon, or bone.
The matrix device is used in conjunction with standard diabetic ulcer care and is made of silicone, cow collagen, and shark cartilage.
